3 hours Oppenheimer Initiates Coverage on Larimar Therapeutics (NASDAQ:LRMR)MarketBeat
Oppenheimer assumed coverage on shares of Larimar Therapeutics in a research note on Wednesday. They issued an “outperform” rating and a $26.00 price objective for the company.
X